Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPN-100 vs NaPBA in Pediatric Urea Cycle Disorders
NCT00947544Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of glycerol phenylbutyrate in urea cycle disorders (UCD), sponsored by Amgen. Started Mar 2010; status: completed.
02
Drugs
glycerol phenylbutyrate
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT00947544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947544.